Interviews/Articles
Selected Publications
2025
2025
Oct. 2025 issue
Under Review/In Press
-
Palomino SM, Levine AA, Liktor-Busa E, Tanguturi P, Streicher JM, and Largent-Milnes TM. HSP90 Inhibition Mitigates facial allodynia in CSD model of headache through modulation of Endocannabinoid System in PAG (accepted Pharmaceutics Oct 2025)
-
Baharamnejad E, Wiese BM, Balasubramanian S, Liktor-Busa E, Largent-Milnes TM, Vanderah TW. Sexual Dimorphism of CB2 Receptors in Murine Respiratory Regulation (Under review, J Cannabinoid Research Oct 2025)
-
Wahl JR, Cooley JK, Martin LF, Ibrahim MM, Liktor-Busa E, Langlais PR, Largent-Milnes TM.. Utilizing the Human Proteome and Phospho Proteome as a Biomarker for Migraine, a Pilot Study (in prep)
Chapters in Scholarly Books and Monographs
1. Salvemini D., T.M. Doyle, T.M. Largent-Milnes, T.W. Vanderah (2018) “The Adenosine Receptor Axis in Chronic Pain”. The Adenosine Receptors. Ed. P.A. Borea, K. Varani, S. Gessi, S. Merighi, and F. Vincenzi. Springer Nature Switzerland AG
2. Liktor-Busa E., A. Levine, T.M. Largent-Milnes (2022) Inhibition of diacylglycerol lipase alpha (DAGLa) as a model for episodic headache in rats: Features and applications. Handbook of Animal Models in Neurological Disorders: Ch. 00024 ed. Martin, Patel, & Preedy
3. Vanderah TW and Largent-Milnes TM. (2023) Cannabinoid Drugs. Basic and Clinical Pharmacology: Ch. 00063 16ed. Katzung and Vanderah
4. Ibrahim MI, Largent-Milnes TM, and Vanderah TW. (2023 in press) Local Anesthetics. Basic and Clinical Pharmacology: Ch. 00026 16ed. Katzung and Vanderah
5. Liktor-Busa E. and T.M. Largent-Milnes (2024) Natural Products Derived from Cannabis sativa for Pain Management. Natural Products as Sources of Noel Drugs (HEP): Ch. 2 ed. Wainwright and Schini-Kerth. doi: 10.1007/164_2024_710
Contact
Information
University of Arizona College of Medicine
(520) 621-2211